๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lung Cancer
Clinical trial register · China

Lung Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 38 Shanghai 34 Beijing 24 Chengdu 13 Wuhan 11
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital of Guangzhou Medical University10 Shanghai Chest Hospital9 Shanghai Pulmonary Hospital, Shanghai, China8 The First Affiliated Hospital of Guangzhou Medical University6 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology5
Site location
Guangzhou38 Shanghai34 Beijing24 Chengdu13 Wuhan11
All 49 locations
Target enrolment
to

Lung Cancer trials in China

134 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
NCT06508307Sarcoma, Cervical Cancer, Colon Cancer, Lung Cancer
GONGCHU Biotechnology Co., Ltd
Phase 1
21
Zhengzhou
2023-04-26
Active, closed
A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer
NCT05690945Lung Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3
606
Guangzhou
2023-02-15
Recruiting
Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients
NCT06790797Lung Cancer, Esophageal Cancer
Zhao Jun
Observational
50
Suzhou
2023-02-12
Active, closed
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
NCT05742204Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
3,700
Hangzhou
2023-02-01
Recruiting
Research on Early Screening and Diagnosis of Pulmonary Nodules Based on Novel Non-invasive Technologies.
NCT07370077Lung Cancer
Chen KeZhong
Observational
1,800
Beijing
2022-12-31
Active, closed
Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
NCT05374603Lung Cancer
AstraZeneca
Phase 2
47
Beijing, Changsha, Chongqing, Hangzhou, Jinan, Kunming, Nanchang, Ningbo
2022-11-15
Active, closed
Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer
NCT05636592Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Observational
250
Yiwu
2022-10-15
Active, closed
MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)
NCT04841811Lung Cancer
Guangdong Association of Clinical Trials
Phase 3
192
Guangzhou
2022-06-20
Recruiting
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
NCT06653478Artificial Intelligence, Deep Learning, Lung Cancer, Lung; Node
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
3,000
Wuhan
2022-06-01
Recruiting
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
NCT05426135Artificial Intelligence, Deep Learning, Lung Cancer, Lung; Node
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
3,000
Wuhan
2022-06-01
Recruiting
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
NCT06019455Lung Cancer, Esophageal Cancer
Sun Yat-sen University
Observational
500
Guangzhou
2022-06-01
Active, closed
Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
NCT05092412Lung Cancer, Extensive-stage Small-cell Lung Cancer, Durvalumab
You Lu
Phase 2
30
Chongqing, Zhengzhou, Chengdu
2022-03-02
Recruiting
China Lung Cancer Screening (CLUS) Study Version 3.0
NCT05494021Lung Cancer
Shanghai Chest Hospital
Not applicable
100,000
Shanghai
2022-01-01
Recruiting
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
NCT05187338Lung Cancer, Liver Cancer, Colorectal Cancer, Pancreas Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2
100
Guangzhou
2021-11-01
Recruiting
Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
NCT05055908Lung Cancer
Hunan Province Tumor Hospital
Phase 3
12,000
Changsha
2021-10-01
Recruiting
MRD Monitoring in Lung Cancer After Resection
NCT04976296Lung Cancer
Guangdong Provincial People's Hospital
Observational
300
Guangzhou
2021-09-01
Recruiting
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
NCT04952272Lung Cancer, Hepatocellular Carcinoma, Solid Tumor
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
50
Guangzhou
2021-03-01
Active, closed
Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC
NCT05400070Sintilimab, Lung Cancer, Anlotinib, Chemotherapy
Tang-Du Hospital
Phase 2
45
Xi'an
2021-03-01
Recruiting
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
NCT04842812Liver Cancer, Lung Cancer, Breast Cancer, Colo-rectal Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
40
Guangzhou
2021-01-01
Recruiting
The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
NCT05477979Lung Cancer, Psychological Stress, Immune Checkpoint Inhibitors, Cancer, Treatment-Related
Second Xiangya Hospital of Central South University
Observational
750
Changsha
2020-06-01
Recruiting
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
NCT04209218Lung Cancer, Surgery, Blood Pressure Management, Dexamethasone
Peking University First Hospital
Not applicable
1,988
Beijing
2020-04-07
Recruiting
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197Lung Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Non Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
60,000
Beijing
2019-11-04
Recruiting
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
NCT04451473Lung Cancer, Surgery, ERAS
The Second Hospital of Shandong University
Not applicable
350
Jinan
2019-10-08
Recruiting
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
NCT06778512Lung, Lung Cancer, Cancer, NSCLC
The First Affiliated Hospital of Guangzhou Medical University
Observational
2,500
Guangzhou
2019-06-01
Recruiting
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
NCT04286841Immunotherapy, Lung Cancer
Guangdong Association of Clinical Trials
Observational
100
Guangzhou
2019-05-01
Recruiting
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
NCT06950697Lung Cancer, Venous Thromboembolism, Arterial Thromboembolism, Immune Checkpoint Inhibitors (ICIs)
Beijing Chao Yang Hospital
Observational
2,400
Zhengzhou, Hohhot, Beijing
2019-01-01
Recruiting
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
NCT03755739Hepatocarcinoma, Lung Cancer, Melanoma, Renal Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
200
Guanzhou
2018-11-01
Recruiting
Survival Outcomes of Lung Cancer
NCT03647098Lung Cancer
Hunan Province Tumor Hospital
Observational
20,000
Changsha
2018-08-01
Recruiting
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05636605Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Observational
200
Yiwu
2018-01-01
Recruiting
iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray
NCT03192501Lung Cancer, Gene Abnormality, Gene Product Sequence Variation, Cancer
Second Affiliated Hospital of Guangzhou Medical University
Observational
250
Guangzhou
2017-07-01
Recruiting
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFฮฒ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
NCT03198052Lung Cancer, Cancer, Immunotherapy, CAR-T Cell
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2017-07-01
Recruiting
Integrative Analysis of Large-cell Lung Cancer
NCT02917369Lung Cancer
Shanghai 10th People's Hospital
Observational
1,000
Ganzhou, Shanghai
2016-01
Recruiting
Non-risk Based Lang Cancer Screening With a One-off LDCT
NCT04938804Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
11,000
Guangzhou
2015-12-12
Active, closed
LDCT Screening in Non-smokers in Taiwan
NCT02611570Lung Cancer
Academia Sinica, Taiwan
Observational
12,000
2014-10
Rows per page Showing 101–134 of 134
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/condition/lung-cancer?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 134 of those studies listing the condition Lung Cancer.

How many Lung Cancer trials are recruiting in China?

104 of the 134 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 16 have not yet opened recruitment, 13 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.